A detailed history of Silvercrest Asset Management Group LLC transactions in Pfizer Inc stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 697,356 shares of PFE stock, worth $19.1 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
697,356
Previous 1,394,712 50.0%
Holding current value
$19.1 Million
Previous $39 Million 50.0%
% of portfolio
0.14%
Previous 0.14%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $17.6 Million - $20.6 Million
-697,356 Reduced 50.0%
697,356 $19.5 Million
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $15.8 Million - $18.5 Million
626,142 Added 81.47%
1,394,712 $39 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $220,453 - $253,150
-8,515 Reduced 1.1%
768,570 $21.3 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $3.43 Million - $4.46 Million
-131,390 Reduced 14.46%
777,085 $22.4 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $25.6 Million - $29.9 Million
-797,788 Reduced 46.76%
908,475 $30.1 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $12.7 Million - $14.7 Million
-352,856 Reduced 17.14%
1,706,263 $62.6 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $2.65 Million - $3.45 Million
-67,286 Reduced 3.16%
2,059,119 $84 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $1.13 Million - $1.47 Million
27,012 Added 1.29%
2,126,405 $109 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $1.52 Million - $1.85 Million
-34,719 Reduced 1.63%
2,099,393 $91.9 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $2.52 Million - $2.99 Million
54,185 Added 2.61%
2,134,112 $112 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $1.08 Million - $1.34 Million
23,694 Added 1.15%
2,079,927 $108 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $90,325 - $133,892
-2,186 Reduced 0.11%
2,056,233 $121 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $1.58 Million - $2.02 Million
-40,155 Reduced 1.91%
2,058,419 $88.5 Million
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $824,709 - $934,256
-22,966 Reduced 1.08%
2,098,574 $82.2 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $1.2 Million - $1.35 Million
35,779 Added 1.72%
2,121,540 $76.9 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $468,144 - $595,286
13,987 Added 0.68%
2,085,761 $76.8 Million
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $224,631 - $263,543
-7,075 Reduced 0.34%
2,071,774 $76 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $641,977 - $778,813
21,314 Added 1.04%
2,078,849 $68 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $12.3 Million - $17.5 Million
454,354 Added 28.34%
2,057,535 $67.2 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $474,607 - $538,619
14,417 Added 0.91%
1,603,181 $62.8 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $668,871 - $867,330
-20,587 Reduced 1.28%
1,588,764 $57.1 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $423,864 - $475,902
-11,462 Reduced 0.71%
1,609,351 $69.7 Million
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $34.9 Million - $38.3 Million
-929,840 Reduced 36.45%
1,620,813 $68.8 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $23.8 Million - $27.1 Million
-617,711 Reduced 19.5%
2,550,653 $111 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $69,353 - $84,121
2,012 Added 0.06%
3,168,364 $140 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $4.97 Million - $5.3 Million
-150,764 Reduced 4.55%
3,166,352 $115 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $1.37 Million - $1.59 Million
43,021 Added 1.31%
3,317,116 $118 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $9.05 Million - $9.6 Million
271,964 Added 9.06%
3,274,095 $119 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $93.1 Million - $103 Million
3,002,131
3,002,131 $107 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.